ESHELMAN FREDRIC N 13D and 13G filings for G1 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-21 4:30 pm Purchase |
2022-11-18 | 13D | G1 Therapeutics, Inc. GTHX |
ESHELMAN FREDRIC N | 4,766,074 9.260% |
1,072,479 (+29.04%) |
Filing |